Home » Newsletters » BioWorld Science

BioWorld Science

April 7, 2022

View Archived Issues

NPC1L1 gene polymorphisms tied to coronary artery calcification

Novel series of glucosylceramide synthase inhibitors presented for treating Parkinson's disease

FDA clears IND for BiOneCure's anti-Trop-2 ADC, BIO-106

BETR-001 shows antidepressant activity in preclinical models

NPO-2270 ameliorates cardiac dysfunction more effectively than enalapril in models of HF

Discovery of noncovalent peptidomimetic proteasome inhibitors for the treatment of MM

Alternate approach could enable earlier detection, intervention, in Alzheimer's

HitGen and Uppthera extend their PROTAC collaboration

Harbour BioMed and AstraZeneca enter global outlicense agreement for HBM-7022

T cell-intrinsic AR activity drives IFN-gamma suppression and immunotherapy resistance

Peptidomimetic TMPRSS2 inhibitor shows prophylactic and therapeutic activity against SARS-CoV-2 VOCs

Medshine Discovery patents new sGC activators

Sunshine Lake Pharma discloses thyroid hormone receptor beta agonists

Aurigene Discovery Technologies presents CREBBP and/or KAT3B inhibitors

Merck & Co. synthesizes new GLCT-1 inhibitors

New TYK2 inhibitors identified by Esker Therapeutics

Emergex collaborates with nonprofit organization to advance yellow fever booster vaccine candidate

IKZF1 gain-of-function variants tied to T/B cell-related immune dysregulation

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 26, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 27, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Muted and missing M&As: JPM deals absent in 2026
BioWorld
For years, the J.P. Morgan Healthcare Conference (JPM) kicked off with splashy headlines of major M&A activity among biopharma companies, but in 2026, the hype...